Summary We have constructed cDNA libraries from the poly(A)+ RNA of normal colonic mucosa and a liver metastasis from a colonic adenocarcinoma. Differential screening of these libraries using 32P-labelled cDNAs transcribed from poly(A)+ RNAs isolated from specimens of four normal colonic mucosae, five adenocarcinomas, and three liver metastases by Grunstein-Hogness and dot-blot hybridisation has identified a number of recombinant cDNA clones homologous to mRNAs that appear to differ significantly in abundance between normal and neoplastic colon and metastases.
One of the major causes of failure in the treatment of colorectal cancer is the occurrence of metastatic disease, involving primarily the liver and lungs, and occasionally bone. By the time of first presentation, between 15-25% of patients have metastases to the liver (Welch & Donaldson, 1978) , while it has been more recently shown that about 30% of patients undergoing apparently curative resection for colorectal cancer possess occult hepatic metastases (Finlay & McArdle, 1982) . Furthermore, in a study of occult metastatic disease using computerised tomography (Finlay & McArdle, 1982) it was shown that the presence or absence of metastatic disease at the time of clinical presentation is the most critical prognostic factor, accounting almost entirely for the observed pattern of mortality. The identification of those patients with occult metastatic disease is clearly of considerable importance in planning therapy and, in addition, would avoid the unnecessary further treatment of that group of patients surgically cured of their disease (Taylor et al., 1985) .
The aggressiveness of colorectal tumours is currently assessed using the Dukes classification (Dukes, 1932) . However, this, together with other prognostic indicators such as tumour morphology and serum levels of carcinoembryonic antigen (CEA), do not reliably correlate with clinical outcome (Finlay & McArdle, 1982; Lewi et al., 1984) . Measurement of DNA distribution patterns in tumour cell nuclei suggest that tumour ploidy may be of prognostic value, non-diploid tumours tending to be more aggressive (Wolley et al., 1982) . The few clinically applicable markers that exist for colorectal cancer are of little specificity either for the diagnosis or for monitoring the course of the disease (Schwartz, 1980) , although it has been suggested that serum levels of CEA (Tate, 1982) and alkaline phosphatase (Aabo et al., 1986 ) may be used as indicators of recurrence and of secondary disease. However, these markers do not allow a distinction between recurrent local and metastatic disease (Hine & Dykes, 1984) .
Although many features of tumour cells have been studied in relation to metastasis (reviewed in Weiss, 1985) , as yet no single variable has been consistently identified as being associated with the metastatic phenotype and there is no clinically reliable means of predicting the metastatic potential of a tumour. Metastasis is considered to be a multistep process (reviewed in Hart & Fidler, 1980; Nicolson, 1982; Schirrmacher, 1985) teristics expressed as a consequence of the activity of many gene loci, and thus would be expected to be reflected in changes in the relative abundances of a number of specific mRNAs.
Variations in the abundances of individual mRNAs can be detected and measured by the application of molecular cloning techniques which allow the identification of previously uncharacterised genes that are associated with a particular cell phenotype. Recombinant complementary DNA (cDNA) libraries have been used, for example, to identify mRNA sequences associated with normal development (Sim et al., 1979) , transformation (Augenlicht & Kobrin, 1982) , dysplastic changes in human colonic mucosa (Bartsch et al., 1986) and to isolate cDNA probes that can be used to classify leukaemias (Weidemann et al., 1983; Warnock et al., 1985; Mars et al., 1985) .
In this paper we describe the application of the same approach to identify some of the genes that are differentially expressed during tumour progression and metastasis in colorectal cancer, which may be expected to be of importance in defining the development of metastases, and of clinical usefulness as prognostic markers of metastases in colorectal cancer. A preliminary account of this work has been published (Elvin et al., 1986 (Grunstein & Hogness, 1975) to the nylon filter replicas of the cDNA libraries was carried out as described by the manufacturer (PALL) at 65°C for at least 12 h using a probe concentration of 0.5-1 x 106 cpm ml -1. Excess probe was removed by three half-hour washes in a washing buffer (5 mM NaH2PO4, 1 mM EDTA, 0.2% SDS) at 65°C. Colony hybridisation was visualised by autoradiography at -70°C using Kodak XOmat film and Dupont Lightning Plus intensifying screens.
Plasmid DNA isolation and dot-blot hybridisation Small-scale bacterial cultures (2 ml overnight cultures) were used for the isolation of plasmid DNA by the method of Birnboim and Doly (1979) . The DNAs were dot blotted onto Biodyne A nylon membrane illcr-s, denatured and baked as described by the manufacturers (PALL) prior to hybridisation under conditions as described for colony hybridisation. For further study plasmids were isolated from 500ml overnight cultures, using the alkaline lysis method of Birnboim and Doly (1979) . The plasmids were purified by CsCl and sucrose gradient centrifugation. Recombinant plasmids were finally resuspended in TE buffer (10mM tris-HCI, 1 mM EDTA, pH 8.0) at a concentration of 250 pg mland stored at 4°C.
Northern blot analysis and dot-blot analysis of total RNA Total and poly(A)+ RNAs in a buffer solution containing 50% formamide and 2.2 M formaldehyde were heated to 65°C for 10min, chilled on ice, and electrophoretically fractionated on 1% agarose-formaldehyde gels prior to Northern blotting onto nitrocellulose as described by Thomas (1980 (Table I) .
On the basis of these semi-quantitative changes in hybridisation signal intensity, four recombinant clones from the normal colonic mucosa library and one recombinant clone from the liver metastasis library were selected for further characterisation by Northern blot and RNA dot-blot analysis.
Characterisation of selected recombinants:
Northern blot analysis Following restriction enzyme digestion of recombinant plasmids, the cDNA inserts in the recombinants pNM 19, pNM32, pNM41 and pNM61 from the normal colonic mucosa library, and pLM59 from the liver metastasis library, were shown to be of between 230-530 bp by agarose gel electrophoresis. Northern blotting of total RNA from a specimen of normal colonic mucosa, followed by hybridisation with nick-translated plasmids, identified these recombinants as being homologous to RNAs of between 0.8 and 2.1 kb (Figure 2 and Table II ). In addition, sequences homologous to the recombinant clone pLM59, which represented an RNA of increased abundance in metastases relative to normal tissue, could be detected in total RNAs from patients both with and without a clinical history of disseminated disease (Figure 3) . Southern blot analysis of EcoRI and HindlIl digested normal human white blood cell DNA (results not shown) indicated that each of these recombinants represented unique RNAs.
RNA dot blot analysis
The relative abundances of RNA sequences homologous to the five recombinants, that on the basis of prior semiquantitative screening, were closely associated with metastases were determined in a series of tissue specimens corresponding to different stages of colorectal tumour progression (see for example Figure 4) . Four of the recombinants, clones pNMl9, pNM32, pNM41 and pNM61, were found to represent RNAs reduced 5-to 10-fold in abundance in metastases relative to primary tumours, and 10-to 14-fold in metastases relative to normal mucosae. One recombinant, clone pLM59, represented an RNA showing a 4-to 6-fold increase in abundance in metastases relative to primary tumours and normal mucosae (Tables III & IV) . To confirm that the observed differences in abundance of Figure 4 Relative abundance of pNM32 RNA at different stages in colorectal tumour progression. The relative abundance of RNA homologous to recombinant plasmid pNM32 in tissue specimens representing different stages of colorectal tumour progression was determined by doubling dilution RNA dot-blot hybridisation to 32P-labelled plasmid DNA. Total RNAs at a concentration of 500igml-1 were diluted and applied to nitrocellulose as described in Materials and methods in a volume of 4,ud, the first dot in each series thus representing 2 jug total RNA.
Other recombinants were screened in an identical manner against an identical series of specimens on replica nitrocellulose filters. Figure 4) , figures in brackets are the range of values. sequences homologous to the cloned cDNAs were due to differences in specific hybridisation and not to errors in the estimates of the RNA content of the samples, the same dot blots were stripped and reprobed with a cloned fragment of human 18S ribosomal DNA (results not shown). RNA dotblot analysis also revealed considerable variation in the abundance of homologous RNAs to the cloned sequences at different stages of tumour progression (Table III) . That these differences were not attributable to degradation of the RNA samples concerned was shown by hybridisation of Northern blots to skeletal muscle actin (Shani et al., 1981) Relative abundance ofpLM59-homologous RNA One of the aforementioned recombinants, pLM59, was of particular interest since it appeared to represent a sequence of greater abundance in liver metastases than in primary tumours and normal tissue, and thus may have the potential clinical application as a marker of metastatic disease. The cDNA isolated by EcoRI/BamHI restriction enzyme digest, and labelled by the 'random primed' method of Feinberg and Vogerstein (1983) , was used to screen a larger series of RNA dot blots (Table V) . The sequence was shown to represent an mRNA of a maximum 4-fold increased abundance in primary tumours, and a maximum 8-fold increased abundance in liver metastases relative to normal mucosae. There was some indication that the levels of pLM59 homologous RNA were slightly elevated in those primary tumours known to have metastasised relative to those that had not, while the levels of homologous RNA in the mucosae showed no differences correlated with the presence or absence of metastatic disease.
Discussion
We previously screened cDNA libraries of about 1,000 recombinant clones from poly(A) + RNAs representing clinically metastasising and non-metastasising variants of colorectal tumours (Kerr et al., 1983) and, although quantitative RNA dot-blot hybridisation analysis identified cDNA clones corresponding to sequences of greater abundance in RNAs from tumours compared to normal mucosae, no clones were found that consistently distinguished between localised and disseminated disease. The present study is based upon the random cloning of cDNAs representing the steady-state levels of total poly(A)+ RNAs from normal mucosa and from a liver metastasis of a colorectal carcinoma. The frequency of a single cloned sequence in the cDNA library reflects the abundance of that sequence in the original mRNA population, and is ultimately determined by the turnover of the corresponding mRNA, which in turn may depend on the parent tissue. The majority of sequences comprising the abundant and moderately abundant classes of mRNA from the 10,000-30,000 different sequences in typical eukaryotic tissues may be expected to be represented in a cDNA library of between 5,000 and 10,000 clones (Williams, 1981) . Thus the libraries screened in this study should have been large enough to contain most abundant and moderately abundant sequences, although low abundance mRNAs will not have been well represented or detected. However, in a study of tissue-related differences in mRNA populations, Hastie and Bishop (1976) concluded that the most striking differences between tissues could be found among the abundant sequences. Furthermore, differences between normal and SV40-transformed human fibroblast mRNA populations could be ascribed to a few sequences of the high abundance mRNA classes (Williams et al., 1977 those recombinants representing abundant RNAs common to normal colonic tissue specimens identified sequences expressed at different levels in primary and secondary tumours. Similarly, screening those recombinants representing sequences common to liver metastases of colorectal tumours identified sequences that represented RNAs associated with colorectal neoplasia and metastasis. Although histologically normal mucosa from tumour-bearing patients may exhibit phenotypic changes associated with the disease (Shamsuddin et al., 1981) , these differences should not have severely masked those specifically associated with transformation or metastasis.
On the basis of colony and plasmid DNA dot hybridisations the vast majority of cDNA clones in the two libraries were found to correspond to abundant RNA sequences shared by both normal and neoplastic colon; most of these sequences were also present in the total poly(A)+ RNA of normal liver. Those sequences showing some variation in abundance associated with tumour development (representing only 0.4% of the total sequences examined) were poorly represented in the poly(A)+ RNA of normal liver, suggesting that the changes in abundance that occur do so in sequences characteristic of the colon. Furthermore, the clones we have identified suggest that the development of metastatic tumour cell populations in colorectal tumours is not solely due to the aberrant expression of one or two genes, but rather to the subtle alteration of multiple genetic loci. The results, however, do not allow any distinction to be made between changes in gene expression that may be associated with the prior existence of metastatic tumour cell populations (Fidler et al., 1978) and those that may arise, for example, as a result of selective pressures exerted by the host microenvironment (Schirrmacher, 1980; Kerbel et al., 1984) .
Changes in gene expression are implied in tumour progression (Foulds, 1975) and the generation of clonal diversity (Nowell, 1976 ) responsible for heterogeneity within tumours for a number of phenotypic characteristics, which may include metastatic capability (Fidler & Hart, 1982) . However, the precise nature of the genetic events associated with tumour progression remain largely undetermined. A number of cellular oncogenes have been identified as being aberrantly expressed in colorectal cancer, including c-mj'c (Rothberg et al., 1985; Stewart et al., 1986 ) c-myb (Alitalo et al., 1984) c-Ha-ras and c-Ki-ras (Spandidos & Kerr, 1984) .
Although decreased levels of p21 ras were demonstrated in metastases, regardless of site, compared to primary colon tumours (Gallick et al., 1985) there appears to be no correlation between the levels of ras-related cellular RNA and clinical outcome with regard to the development of metastatic disease . Amplification of c-myc may be correlated with tumour metastasis (Yokota et al., 1986 ) and the transfection of cellular oncogenes (Thorgeirsson et al., 1985) has shown them to be involved in the acquisition of metastatic capability. Thus, although much has been learned of the role of oncogenes in the process of transformation, their role in metastasis is not clear, and it is likely that other, as yet uncharacterised sequences (e.g. Bernstein & Weinberg, 1985) , may be related to the events associated with the activation of oncogenes and other genes during the metastatic process. In this regard pLM59 appears to represent a hitherto unknown gene (no homologous sequence was found in the Genbank sequence data bank) whose expression is at least correlated with the process of metastasis in colorectal cancer.
The significance of increases and decreases in abundance of specific sequences of the order that we have reported, and the effects of these changes in the complex pattern of events associated with colorectal tumour development and metastasis, are not yet known. The validity of the results with respect to mRNA abundance also requires confirmation in a larger series of specimens. The use of in situ hybridisation to examine the localisation of mRNAs homologous to the cloned sequences in both primary and secondary tumour cell populations and the analysis of the sequences involved may clarify this. These sequences may also prove to be of considerable prognostic value in predicting the metastatic capability of primary tumours at the time of surgery.
